Stocksigma LogoStocksigma Logo

Medicamen Biotech Approves Equity Allotment via Warrant Conversion

Medicamen Biotech Limited's Preferential Issue Committee approved the allotment of 5,00,000 equity shares upon conversion of equivalent fully convertible

Medicamen Biotech Approves Equity Allotment via Warrant Conversion

Medicamen Biotech Ltd 路 Others (Uncategorized) 路 23 Oct 2026, 5:31 pm

Medicamen Biotech Approves Equity Allotment via Warrant Conversion Medicamen Biotech Limited's Preferential Issue Committee approved the allotment of 5,00,000 equity shares upon conversion of equivalent fully convertible warrants on 23rd Oct'26. The shares were allotted to promoter group entity Shivalik Rasayan Limited at an issue price of Rs. 530 per share for cash, aggregating to Rs. 26.50 crore. Post-allotment, the company's paid-up equity share capital expanded to Rs. 14.06 crore, comprising 1,40,62,815 equity shares of face value Rs. 10 each.

Original exchange filing (PDF)

More announcements from Medicamen Biotech Ltd

All Medicamen Biotech Ltd announcements